NITROPRESS
Total Payments
$34,200
Transactions
2
Doctors
1
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $4,200 | 1 | 1 |
| 2017 | $30,000 | 1 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $34,200 | 2 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| 2015-32 Adler | Valeant Pharmaceuticals North America LLC | $30,000 | 1 |
| 2015-32 Adler | Bausch Health US, LLC | $4,200 | 1 |
Top Doctors Receiving Payments for NITROPRESS
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD PHD | Endocrinology, Diabetes & Metabolism | Boston, MA | $34,200 | 2 |
Ad
Manufacturing Companies
- Valeant Pharmaceuticals North America LLC $30,000
- Bausch Health US, LLC $4,200
Product Information
- Type Drug
- Total Payments $34,200
- Total Doctors 1
- Transactions 2
About NITROPRESS
NITROPRESS is a drug associated with $34,200 in payments to 1 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is Valeant Pharmaceuticals North America LLC.
Payment data is available from 2017 to 2018. In 2018, $4,200 was paid across 1 transactions to 1 doctors.
The most common payment nature for NITROPRESS is "Unspecified" ($34,200, 100.0% of total).
NITROPRESS is associated with 2 research studies, including "2015-32 Adler" ($30,000).